Back to calendar
Allogene Therapeutics, Inc. (ALLO) Earnings
ALLO reports earnings on Thursday, October 29, 2026
earnings report
October 29, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.15
Actual EPS: $-0.13
Company overview
Market Cap$691.0M
SectorHealth Technology
IndustryBiotechnology